Charles River Laboratories International (CRL) Profit Metrics
Price: $155.55
Market Cap: $7.96B
Avg Volume: 1.15M
Market Cap: $7.96B
Avg Volume: 1.15M
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Profit Metrics Summary (Annual)
According to Charles River Laboratories International's latest annual financial reports:
- The company has reported a gross profit of 1.33B, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 32.88%, with a year-over-year growth of -11.36%.
- Charles River Laboratories International's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 581.14M. The EBITDA margin stands at 14.35%, showing a growth of -43.69% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at 227.35M. The operating margin is 5.61%, with a year-over-year growth of -63.17%.
- The net income, which shows the company's total earnings or profit after all expenses, is 22.20M. The net profit margin is 0.55%, demonstrating a growth of -95.32% from the previous year.
These metrics provide a comprehensive overview of Charles River Laboratories International's profitability and operational efficiency over the past year.
Gross Profit
$1.33B
Gross Profit Margin (2023)
32.88%
EBITDA
$581.14M
EBITDA Margin
14.35%
Operating Income (2023)
$227.35M
Operating Margin
5.61%
Net Income
$22.20M
Net Profit Margin
0.55%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
Charles River Laboratories International Historical Profit Metrics
Charles River Laboratories International Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $1.33B | -11.36% | $227.35M | -63.17% | $22.20M | -95.32% | $581.14M | -43.69% |
| 2023 | $1.50B | 2.73% | $617.26M | -5.18% | $474.62M | -2.39% | $1.03B | -0.36% |
| 2022 | $1.46B | 9.59% | $650.98M | 10.36% | $486.23M | 24.36% | $1.04B | 21.25% |
| 2021 | $1.33B | 24.32% | $589.86M | 36.31% | $390.98M | 7.32% | $854.29M | 12.53% |
| 2020 | $1.07B | 12.02% | $432.73M | 23.23% | $364.30M | 44.55% | $759.15M | 30.50% |
| 2019 | $958.31M | 14.08% | $351.15M | 5.97% | $252.02M | 11.33% | $581.73M | 14.69% |
| 2018 | $840.07M | 19.61% | $331.38M | 15.26% | $226.37M | 83.51% | $507.23M | 10.78% |
| 2017 | $702.31M | 8.61% | $287.50M | 21.09% | $123.36M | -20.30% | $457.89M | 21.36% |
| 2016 | $646.67M | 21.76% | $237.42M | 15.00% | $154.76M | 3.65% | $377.29M | 23.55% |
| 2015 | $531.09M | 12.36% | $206.45M | 16.20% | $149.31M | 17.85% | $305.38M | 6.78% |
| 2014 | $472.66M | 19.69% | $177.67M | 17.35% | $126.70M | 23.21% | $285.99M | 11.91% |
| 2013 | $394.90M | 0.72% | $151.40M | -8.67% | $102.83M | 5.69% | $255.54M | 4.58% |
| 2012 | $392.08M | -2.53% | $165.76M | -4.90% | $97.30M | -11.20% | $244.36M | -6.19% |
| 2011 | $402.24M | 4.54% | $174.31M | 158.39% | $109.57M | 132.54% | $260.48M | 226.97% |
| 2010 | $384.76M | -10.39% | $-298.51M | -278.83% | $-336.67M | -394.19% | $-205.15M | -177.95% |
| 2009 | $429.37M | -15.93% | $166.93M | 137.11% | $114.44M | 121.93% | $263.20M | 173.97% |
| 2008 | $510.71M | 6.80% | $-449.76M | -297.97% | $-521.84M | -437.97% | $-355.82M | -210.57% |
| 2007 | $478.19M | 17.61% | $227.19M | 20.74% | $154.41M | 376.80% | $321.81M | 17.75% |
| 2006 | $406.61M | -5.16% | $188.17M | 3.95% | $-55.78M | -139.28% | $273.30M | -0.55% |
| 2005 | $428.74M | 43.60% | $181.02M | 12.91% | $142.00M | 58.14% | $274.81M | 30.46% |
Related Metrics
Explore detailed financial metrics and analysis for CRL.